Tailoring echistatin to possess higher affinity for integrin alpha(IIb)beta(3).

A mutant of echistatin, a disintegrin with a high affinity for the integrins, was constructed by substituting CRGDC for ARGDD in the Arg-Gly-Asp (RGD) region. The mutant was chemically synthesized, subjected to a folding process with air oxidation, and purified by reverse-phase HPLC. The peptide mapping and mass spectrometric analyses revealed that the two Cys residues introduced in the mutant are linked to each other, without any effect on the mode of the four disulfide bonds present in native echistatin, as expected. The mutant strongly inhibited the binding of human fibrinogen to its receptor, integrin alpha(IIb)beta(3) with an IC(50) value of 0.12 nM. This value shows that the mutant is twice as potent as the native form (IC(50) = 0.23 nM). These results indicate that the native disintegrin molecule, which has been considered to possess the optimum affinity for the integrins, can be tailored to exhibit even higher affinity by introducing the conformational constraint into the RGD region. Monte Carlo simulations of KRCRGDCMD, the RGD region in the mutant, suggested that the disulfide bond constrains the RGD region to assume a type II' beta-turn, with Gly and Asp in positions 2 and 3 of the turn.